Protein phosphatase 2A anchoring disruptor gene therapy for familial dilated cardiomyopathy is a research paper published in Molecular Therapy — Methods & Clinical Development (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI
Grant: R01HL146111
NHLBI
Grant: R01HL158052
NHLBI
Grant: R01HL153835
NHLBI
Grant: T32HL094274
National Institutes of Health
Grant: 1R01HL153835-01A1
Perinuclear Signaling and Cardiac Hypertrophy
National Institutes of Health
Grant: 1R01HL158052-01
Calcineurin compartmentation and regulation of pathological cardiac remodeling
National Institutes of Health
Grant: 3R01HL146111-03S1
Regulation of Histone Deacetylases by mAKAP Signalosomes
National Institutes of Health
Grant: 5T32HL094274-13
Training in Myocardial Biology at Stanford
National Institutes of Health
Stanford University
Fields of Study
Keywords
Sustainable Development Goals